Gene-transfer systems for human endothelial cells

Advanced Drug Delivery Reviews

Volumn 41, Issue 2, 2000, Pages 223-233

  Martin, S G ^a   Murray, J C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Endothelium; Gene therapy; Transduction; Transfection; Viral infection

Indexed keywords

BACTERIA; CYTOLOGY; DNA; GENE TRANSFER; GENES; NUCLEIC ACIDS; PHARMACOKINETICS; TISSUE;

ENDOTHELIAL CELLS; ENDOTHELIUM; GENE THERAPY; TRANSFECTION; VIRAL MEDIATED TRANSDUCTION;

CELLS;

BETA GALACTOSIDASE; VIRUS VECTOR;

ANIMAL CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVIEW;

EID: 0343938830     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(99)00068-X     Document Type: Article

References (48)

1. Kumar S., West D.C., Ager M. Heterogeneity in endothelial cells from large vessels and microvessels. Differentiation. 36:1987;57-70.
2. Bicknell R. Endothelial Cell Culture - Handbooks in Practical Animal Cell Biology. 1996;Cambridge University Press, Cambridge, UK.
3. Graham F.L., van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456.
4. Vaheri A., Pagano J.S. Infectious poliovirus RNA: A sensitive method of assay. Science. 175:1965;434.
5. Hanemaaijer R., Arts J., le Clerq L., Kooistra T., van Hinsbergh V. Plasminogen activator regulation studies following transfection of human endothelial cells. Fibrinolysis. 8:1994;19-21.
6. Sun B., Plumpton C., Sinclair J.H., Brown M.J. In vitro expression of calcitonin gene-related peptide in human endothelial cells transfected with plasmid and retroviral vectors. Neuropeptides. 26:1994;167-173.
7. Tanner F.C., Carr D.P., Nabel G.J., Nabel E.G. Transfection of human endothelial cells. Cardiovasc. Res. 35:1997;522-528.
8. Araki S., Shimada Y., Kaji K., Hayashi H. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem. Biophys. Res. Commun. 168:1990;1194-1200.
9. Ozaki K., Yoshida T., Ide H., Saito I., Ikeda Y., Sugimura T., Terada M. Use of von Willebrand factor promoter to transduce suicidal gene to human endothelial cells HUVEC. Hum. Gene Ther. 7:1996;1483-1490.
10. Siphehia R., Martucci G. High-efficiency transformation of human endothelial cells by Apo E-mediated transfection with plasmid DNA. Biochem. Biophys. Res. Commun. 214:1995;206-211.
11. Curiel D.T., Agarwal S., Wagner E., Cotten M. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc. Natl. Acad. Sci. USA. 88:1991;8850-8854.
12. Cotten M., Wagner E., Zatloukal K., Philips S., Curiel D.T. High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenoviral particles. Proc. Natl. Acad. Sci. USA. 89:1992;6099-6103.
13. Nathwami A.C., Gale K.M., Pemberton K.D., Crossman D.C., Tuddenham E.G.D., McVey J.H. Efficient gene transfer into human umbilical vein endothelial cells allows functional analysis of the human tissue factor gene promoter. Br. J. Haematol. 88:1994;122-128.
14. Schwachtgen J.-L., Ferreira V., Meyer D., Keririou-Nabias D. Optimisation of the transfection of human endothelial cells by electroporation. BioTechniques. 17:1994;882-887.
15. Wei C.M., Gibson M., Spear P.G., Scolnick E.M. Construction and isolation of a transmissable retrovirus containing the src gene of harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1. J. Virol. 39:1981;935-944.
16. Anderson W.F., Blaese R.M., Culver K. The ADA human gene therapy clinical protocol. Hum. Gene Ther. 1:1990;331-362.
17. Miller D.G., Adam M.A., Miller D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:1990;4239-4242.
18. Ojeifo J.O., Ning S., Ryan U.S., Verma U.N., Mazumder A., Zwiebel J.A. Towards endothelial cell-directed cancer immunotherapy: in vitro expression of human recombinant cytokine genes by human and mouse primary cells. Cytokines Mol. Ther. 2:1996;89-101.
19. Inaba M., Toninelli E., Vanmeter G., Bender J.R., Conte M.S. Retroviral gene transfer: Effects on endothelial cell phenotype. J. Surg. Res. 78:1998;31-36.
20. Eton D., Terramani T.T., Wang Y., Takahashi A.M., Nigro J.J., Tang L., Yu H. J. Vasc. Surg. 29:1999;863-873.
21. Fallaux F.J., Kranenberg O., Cramer S.J., Houweling A., van Ormondt H., Hoeben R.C., van der Eb E.B. Characterisation of 911: A new helper line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 7:1996;215-222.
22. Graham F.L. Covalently closed circles of human adenovirus DNA are infectious. EMBO J. 3:1984;2917-2922.
23. Bett A.J., Haddara W., Prevec L., Graham F.L. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early region-1 and region-3. Proc. Natl. Acad. Sci. USA. 91:1994;8802-8806.
24. - vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. J. Virol. 69:1995;6839-6846.
25. Yeh P., Dedieu J.-F., Orsini C., Vigne E., Denefle P., Perricaudet G. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J. Virol. 70:1996;559-565.
26. Wang Q., Finer M.H. Second-generation adenovirus vectors. Nat. Med. 2:1996;714-716.
27. DeMatteo R.P., Raper S.E., Ahn M., Fisher K.J., Burke C., Radu A., Widera G., Claytor B.R., Barker C.F., Markmann J.F. Gene transfer to the thymus: A means of abrogating the immune response to recombinant adenovirus. Ann. Surg. 222:1995;229-242.
28. Nguyen T.T., Nery J.P., Rocha C.E., Carney G.E., Spindler K.R., Villarraeal L.P. Mouse adenovirus (MAV-1) expression in primary human endothelial cells and generation of a full-length infectious plasmid. Gene Ther. 6:1999;1291-1297.
29. DeMartin R., Raidl M., Hofer E., Binder B.R. Adenovirus-mediated expression of green fluorescent protein. Gene Ther. 4:1997;493-495.
30. 1-antitrypsin cDNA to human endothelial cells. Proc. Natl. Acad. Sci. USA. 89:1992;6482-6486.
31. Erzurum S.P., Lemarchand P., Rosenfeld M.A., Yoo J.-H., Crystal R.G. Protection of human endothelial cells from oxidant injury by adenoviral-mediated transfer of the human catalase cDNA. Nucleic Acids Res. 21:1993;1607-1612.
32. Fernandez H.A., Kallenbach K., Seghezzi G., Mehrara B., Apazidis A., Baumann F.G., Grossi E.A., Colvin S., Mignatti P., Galloway A.C. Modulation of matrix metalloproteinase activity in human saphenous vein grafts using adenovirus-mediated gene transfer. Surgery. 124:1998;129-136.
33. Kotin R.M., Siniscalo M., Sumulski R.J., Zhu X.D., Hunter L., Laughlin C.A. Site-specific integration by adenoassociated virus. Proc. Natl. Acad. Sci. USA. 87:1990;2211-2215.
34. Kotin R.M., Linden R.M., Berns K.I. Characterisation of a preferred site on human chromosome 19q for integration of adeno-associated virus by non-homologous recombination. EMBO J. 11:1992;5071-5078.
35. Lynch C.M., Hara P.S., Koudy J., Dean R.H., Geary R.L. Adeno-associated virus vectors for vascular gene delivery. Circ. Res. 80:1997;497-505.
36. Gorman C.M., Moffat L.F., Howard B.H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
37. Macgregor G.R., Nolan G.P., Fiering S., Roederer M., Herzenberg L.A. Use of E. coli lacZ (β-galactosidase) as a reporter gene. Marray E.J. Methods in Molecular Biology. Gene Transfer and Expression Protocols. Vol. 7:1991;217-235 Humana Press, New Jersey.
38. Feirrera V., Assouline Z., Schwachtgen J.-L., Bahnak B.R., Meyer D., Kerbiriou-Nabias D. The role of the 5′-flanking region in the cell-specific transcription of the human von Willebrand factor gene. Biochem. J. 293:1993;641-648.
39. Jahroudi N., Lynch D.C. Endothelial cell-specific regulation of von Willebrand factor gene expression. Mol. Cell. Biol. 14:1994;999-1008.
40. Patterson C., Wu Y.X., Lee M.E., Devault J.D., Runge M.S., Haber E. Nuclear protein interactions with the human KDR/flk-1 promoter in vivo - Regulation of Sp1 binding is associated with cell type-specific expression. J. Biol. Chem. 272:1997;8410-8416.
41. Morishita K., Johnson D.E., Williams L.T. A novel promoter for vascular endothelial cell growth factor receptor (flt-1) that confers endothelial-specific gene expression. J. Biol. Chem. 270:1995;27948-27953.
42. Cowan P.J., Tsang D., Pedic C.M., Abbott L.R., Shinkel T.A., d'Apice A.J.F., Pearse M.J. The human ICAM-2 promoter is endothelial cell-specific in vitro and in vivo and contains critical SP1 and GATA binding sites. J. Biol. Chem. 273:1998;11737-11744.
43. Whelan J., Ghersa P., Vanhuijsduijnen R.H., Gray J., Chandra G., Talbot F. An NFκβ-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule-1 (ELAM-1) gene transcription. Nucleic Acid Res. 19:1991;2645-2653.
44. Smith G.M., Whelan J., Pescini R., Ghersa P., Delamarter J.F., Vanhuijsduijnen R.H. DNA-methylation of the E-selectin promoter represses NFκβ transactivation. Biochem. Biophys. Res. Commun. 194:1993;215-221.
45. Pan J., McEver R.P. Characterisation of the promoter for the human P-selectin gene. J. Biol. Chem. 268:1993;22600-22608.
46. Pan J., Xia L., McEver R.P. Comparison of promoters for the murine and human P-selectin genes suggests a species-specific and conserved mechanism for transcriptional regulation in endothelial cells. J. Biol. Chem. 273:1998;10058-10067.
47. Iademarco M.F., McQuillan J.J., Rosen G.D., Dean D.C. Characterisation of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267:1992;16323-16329.
48. Neish A.S., Kachigian L.M., Park A., Baichwal V.R., Collins T. Sp1 is a component of the cytokine-inducible enhancer in the promoter of vascular cell adhesion molecule-1. J. Biol. Chem. 270:1995;28903-28909.